BBSC - ETF AI Analysis
Top Page
JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of the returns generated by the portfolio.
Broad Sector Diversification
Holdings are spread across many sectors, including technology, health care, financials, and industrials, which helps reduce the impact of weakness in any single industry.
Negative Factors
Heavy U.S. Focus
Almost all of the ETF’s assets are invested in U.S. companies, offering very limited international diversification.
Small-Cap Volatility Risk
Because the fund targets smaller companies, its share price can be more sensitive to market swings and economic downturns.
Concentration in Top Sectors
A large portion of the portfolio is concentrated in technology, health care, and financials, which could hurt performance if these areas weaken.
BBSC vs. SPDR S&P 500 ETF (SPY)
AUM703.47M
RegionNorth America
Expense Ratio0.09%
Beta1.11
IssuerJPMorgan
Inception DateNov 16, 2020
Dividend Yield1.02%
Asset ClassEquity
Index TrackedMorningstar US Small Cap Target Market Exposure Extended Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume6,357
30 Day Avg. Volume10,014
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
109.81Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering849
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BBSC Summary
JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) is an ETF that follows the Morningstar US Small Cap Target Market Exposure Extended Index, focusing on smaller U.S. companies with room to grow. It holds hundreds of stocks across many sectors, including technology, health care, and financials. Some recognizable names in the fund are Semtech and DigitalOcean Holdings. Investors might consider BBSC to add diversification and long-term growth potential from smaller, more innovative businesses. A key risk is that small-cap stocks can be more volatile than larger companies, so the value of this ETF can go up and down sharply with the market.
How much will it cost me?The JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s passively managed, aiming to track an index rather than actively selecting stocks.
What would affect this ETF?The BBSC ETF, focused on U.S. small-cap stocks, could benefit from economic growth and innovation within sectors like technology, health care, and industrials, as smaller companies often thrive during periods of expansion. However, it may face challenges from rising interest rates, which can increase borrowing costs for small-cap firms, and economic slowdowns that disproportionately impact smaller businesses. Additionally, sector-specific risks, such as regulatory changes in health care or energy, could influence performance.
BBSC Top 10 Holdings
BBSC leans into U.S. small caps with a clear tilt toward tech and health care, and that’s where most of the action is. DigitalOcean and Corcept Therapeutics have been rising sharply, giving the fund a helpful push, while BrightSpring and Arrowhead add more health care fuel to the rally despite their financial quirks. On the flip side, Semtech and FormFactor have been lagging lately, acting like a bit of sand in the ETF’s gears. With all holdings U.S.-based, this is a domestically focused, innovation-heavy small-cap bet.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 1.04% | $7.25M | ― | ― | ― | |
| Moog | 0.46% | $3.21M | $13.18B | 112.13% | 73 Outperform | |
| Semtech | 0.44% | $3.07M | $10.37B | 92.79% | 69 Neutral | |
| American Healthcare REIT, Inc. | 0.43% | $2.99M | $12.04B | 51.62% | 64 Neutral | |
| BrightSpring Health Services, Inc. | 0.42% | $2.95M | $14.22B | 260.50% | 67 Neutral | |
| Arrowhead Pharmaceuticals | 0.41% | $2.87M | $12.08B | 449.00% | 57 Neutral | |
| CareTrust REIT | 0.36% | $2.53M | $10.09B | 36.82% | 80 Outperform | |
| Krystal Biotech | 0.35% | $2.46M | $10.74B | 137.72% | 80 Outperform | |
| DigitalOcean Holdings | 0.35% | $2.46M | $13.15B | 304.71% | 73 Outperform | |
| Corcept Therapeutics | 0.35% | $2.44M | $10.11B | 34.73% | 76 Outperform |
BBSC Technical Analysis
Neutral
―
Price Trends
88.19
Positive
83.72
Positive
79.84
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBSC, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 90.02, equal to the 50-day MA of 88.19, and equal to the 200-day MA of 79.84, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BBSC.
BBSC Peer Comparison
Comparison Results
Performance Comparison
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
88.53
22.00
33.07%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
SMDV
ProShares Russell 2000 Dividend Growers ETF
―
―
―
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents